UA81940U - Method for increasing gastroprotection potential in children with chronic gastroduodenitis and zinc deficiency - Google Patents
Method for increasing gastroprotection potential in children with chronic gastroduodenitis and zinc deficiencyInfo
- Publication number
- UA81940U UA81940U UAU201302224U UAU201302224U UA81940U UA 81940 U UA81940 U UA 81940U UA U201302224 U UAU201302224 U UA U201302224U UA U201302224 U UAU201302224 U UA U201302224U UA 81940 U UA81940 U UA 81940U
- Authority
- UA
- Ukraine
- Prior art keywords
- gastroprotection
- children
- potential
- increasing
- zinc deficiency
- Prior art date
Links
- 206010048714 Gastroduodenitis Diseases 0.000 title abstract 3
- 206010048259 Zinc deficiency Diseases 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 229940118149 zinc sulfate monohydrate Drugs 0.000 abstract 1
- RNZCSKGULNFAMC-UHFFFAOYSA-L zinc;hydrogen sulfate;hydroxide Chemical compound O.[Zn+2].[O-]S([O-])(=O)=O RNZCSKGULNFAMC-UHFFFAOYSA-L 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for increasing the gastroprotection potential in the children with the chronic gastroduodenitis and zinc deficiency provides for the use of vitamin and mineral complex at the second step of the treatment. Following the course of ahtihelicobacterial therapy of H. pylori associated gastroduodenitis or following antisecretory drugs in hyperacidic variant in the setting of the secretion stimulators in hypoacidic variant, zinc sulfate monohydrate at a dose of 124 mg is provided for one month.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201302224U UA81940U (en) | 2013-02-22 | 2013-02-22 | Method for increasing gastroprotection potential in children with chronic gastroduodenitis and zinc deficiency |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201302224U UA81940U (en) | 2013-02-22 | 2013-02-22 | Method for increasing gastroprotection potential in children with chronic gastroduodenitis and zinc deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA81940U true UA81940U (en) | 2013-07-10 |
Family
ID=52024907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201302224U UA81940U (en) | 2013-02-22 | 2013-02-22 | Method for increasing gastroprotection potential in children with chronic gastroduodenitis and zinc deficiency |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA81940U (en) |
-
2013
- 2013-02-22 UA UAU201302224U patent/UA81940U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017014338A (en) | Targeted selection of patients for treatment with cortistatin derivatives. | |
| MX2021004828A (en) | Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy. | |
| MX378263B (en) | Combination therapy for the treatment of cancer | |
| MX2020003719A (en) | Therapy involving antibodies against claudin 18.2 for treatment of cancer. | |
| MY189466A (en) | Methods of modulating drug plasma levels using erythrohydroxybupropion | |
| PH12017502142A1 (en) | Tetrasubstituted aklene compounds and their use | |
| NZ719049A (en) | Cancer treatment with combination of plinabulin and taxane | |
| MX2024002360A (en) | USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONRIAL DISORDERS. | |
| EP3421039A4 (en) | Drug for cancer therapy characterized by administering combination between axl inhibitor and immune checkpoint inhibitor | |
| UA117581C2 (en) | Low-dose antitumor agent including irinotecan hydrochloride hydrate | |
| MY189663A (en) | Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer | |
| MX2016016388A (en) | Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds. | |
| NZ598171A (en) | Methods and compositions for treating thyroid-related medical conditions with reduced folates | |
| EP2786764A3 (en) | Combination therapy using anti-c-met antibody and sorafenib | |
| UA81940U (en) | Method for increasing gastroprotection potential in children with chronic gastroduodenitis and zinc deficiency | |
| NZ712584A (en) | Antitumor agent including irinotecan hydrochloride hydrate | |
| UA90823U (en) | Method for preventing acute conditions in children with chronic gastroduodenitis and zinc deficiency | |
| UA100992U (en) | Method of treatment hypertonic-hyperkinetic forms of biliary dyskinesia and vegetative disorders in patients with chronic acalculous cholecystitis | |
| UA78790U (en) | Method for treating chronic pyelonephritis | |
| UA84693U (en) | Method for treating non-alcoholic steatohepatitis in combination with chronic bronchitis in setting of obesity | |
| UA88668U (en) | Method for treating ischemic heart disease with concomitant metabolic syndrome in setting of vitamin d deficiency | |
| UA93428U (en) | Method for treating high grade of lipidemia | |
| UA86751U (en) | Method for treating excess body mass in nicotine-addicted patients at stage of remission | |
| UA75277U (en) | Method for treating dystrophic diseases of retina and choroid | |
| UA89203U (en) | Method for correcting vegetative dysfunction in children and adolescents with secondary cardiomyopathy |